Document Type : Original Article

Authors

1 School of Medicine, Tehran University of Medical Sciences, International Campus, Tehran, Iran Universal Scientific Education and Research Network, Tehran, Iran

2 Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

3 School of Medicine, Tehran University of Medical Sciences, International Campus, Tehran, Iran

4 School of Medicine, Tehran University of Medical Sciences, International Campus, Tehran, Iran School of Health Science, Department of Public Health, National Open University of Nigeria, Abuja, Nigeria

Abstract

Background: Multiple sclerosis (MS) is a widespread autoimmune disease that affects millions of people globally. Depression among patients with MS remains poorly understood. Self-awareness, the recognition of one's emotions and limitations, has emerged as a potential factor that influences mental health. This study assessed self-awareness and its link to depression in patients with MS, thus contributing to mental health knowledge. These findings may inform targeted interventions to achieve better outcomes.
Methods: This cross-sectional study assessed the self-awareness of patients with MS and included 97 patients referred to the MS Research Center at Sina Hospital, Tehran, Iran. Self-awareness was evaluated using the Self-Consciousness Scale-Revised (SCS-R). Depression was measured using the Beck Depression Inventory-Second Edition (BDI-II). SCS-R and BDI-II scores were calculated separately for each category. Participants completed an online questionnaire.
Results: The mean age of participants was 38.66 years. Family history was positive in 18.6% of the participants. The mean BDI-II was 18.40 ± 12.32. The mean for private self-consciousness was 10.28 ± 2.77, and for public self-consciousness and social anxiety was 13.32 ± 3.57 and 13.32 ± 3.40, respectively. A significant association was observed between self-awareness and BDI-II (P < 0.05).
Conclusion: There is a statistically significant link between specific sub-categories of self-awareness and severity of depression in patients with MS. Patients with MS have low private self-consciousness scores and high scores on public self-consciousness, whereas the average score was noted for social anxiety. Concealed prognostic factors might be linked to self-awareness in individuals living with MS. Therefore, additional studies further examining these factors are highly endorsed.

Keywords

Main Subjects

  1. Lassmann H. Multiple Sclerosis Pathology. Cold Spring Harb Perspect Med 2018; 8(3): a028936.
  2. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 2020; 26(14): 1816-21.
  3. Gholipour T, Healy B, Baruch NF, Weiner HL, Chitnis T. Demographic and clinical characteristics of malignant multiple sclerosis. Neurology 2011; 76(23): 1996-2001.
  4. Confavreux C, Vukusic S. Natural history of multiple sclerosis: A unifying concept. Brain 2006; 129(Pt 3): 606-16.
  5. Goverover Y, Genova H, Griswold H, Chiaravalloti N, DeLuca J. Metacognitive knowledge and online awareness in persons with multiple sclerosis. NeuroRehabilitation 2014; 35(2): 315-23.
  6. Strober LB. Personality in multiple sclerosis (MS): Impact on health, psychological well-being, coping, and overall quality of life. Psychol Health Med 2017; 22(2): 152-61.
  7. Cheek J, Briggs S. Self-consciousness and aspects of identity. J Res Pers 1982; 16(4): 401-8.
  8. Morrison AS, Heimberg RG. Social anxiety and social anxiety disorder. Annu Rev Clin Psychol 2013; 9: 249-74.
  9. Mazancieux A, Souchay C, Casez O, Moulin CJA. Metacognition and self-awareness in Multiple Sclerosis. Cortex 2019; 111: 238-55.
  10. Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 2004; 14(3 Suppl): 36s-45s.
  11. Goverover Y, Chiaravalloti N, Gaudino-Goering E, Moore N, DeLuca J. The relationship among performance of instrumental activities of daily living, self-report of quality of life, and self-awareness of functional status in individuals with multiple sclerosis. Rehabil Psychol 2009; 54(1): 60-8.
  12. Beatty WW, Monson N. Metamemory in multiple sclerosis. J Clin Exp Neuropsychol 1991; 13(2): 309-27.
  13. Mazancieux A, Moulin CJA, Casez O, Souchay C. A Multidimensional Assessment of Metacognition Across Domains in Multiple Sclerosis. J Int Neuropsychol Soc 2021; 27(2): 124-35.
  14. Maor Y, Olmer L, Mozes B. The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients--the role of depression. Mult Scler 2001; 7(2): 131-5.
  15. Rosti-Otajärvi E, Ruutiainen J, Huhtala H, Hämäläinen P. Relationship between subjective and objective cognitive performance in multiple sclerosis. Acta Neurol Scand 2014; 130(5): 319-27.
  16. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162-73.
  17. Scheier MF, Carver CS. The Self‐Consciousness Scale: A revised version for use with general populations 1. J Appl Soc Psychol 1985; 15(8): 687-99.
  18. Beck AT, Steer RA, Brown G. Beck depression inventory-II. Washington, DC: American Psychological Association; 1996.
  19. Rosner RI. Beck Depression Inventory (BDI). The Encyclopedia of Clinical Psychology. New Jersey, NJ: John Wiley & Sons; 2014.
  20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33(11): 1444-52.
  21. Mozo-Dutton L, Simpson J, Boot J. MS and me: Exploring the impact of multiple sclerosis on perceptions of self. Disabil Rehabil 2012; 34(14): 1208-17.
  22. Goverover Y, Chiaravalloti N, DeLuca J. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Mult Scler 2005; 11(2): 203-12.
  23. Reich E, Arias E, Torres C, Halac E, Carlino M. Anosognosia and self-awareness in multiple sclerosis. J Neurol Sci 2015; 357(1): e317.
  24. Chen M, Goverover Y. Intellectual Awareness but Not Online Awareness is Impaired in Multiple Sclerosis. Arch Phys Med Rehabil 2020; 101(11): e60-e1.
  25. Benedict RH, Schwartz CE, Duberstein P, Healy B, Hoogs M, Bergsland N, et al. Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis. Psychosom Med 2013; 75(3): 253-61.
  26. Scheier MF, Carver CS, Gibbons FX. Self-directed attention, awareness of bodily states, and suggestibility. J Pers Soc Psychol 1979; 37(9): 1576-88.
  27. Scheier MF. Effects of public and private self-consciousness on the public expression of personal beliefs. J Pers Soc Psychol 1980; 39(3): 514-21.
  28. Scheier MF, Buss AH, Buss DM. Self-consciousness, self-report of aggressiveness, and aggression. J Res Pers 1978; 12(2): 133-40.
  29. Scheier MF. Self-awareness, self-consciousness, and angry aggression. J Pers 1976; 44(4): 627-44.
  30. Scheier MF, Carver CS. Self-focused attention and the experience of emotion: Attraction, repulsion, elation, and depression. J Pers Soc Psychol 1977; 35(9): 625-36.
  31. Franzoi SL. Self-concept differences as a function of private self-consciousness and social anxiety. J Res Pers 1983; 17(3): 275-87.
  32. Turner RG. Effects of differential request procedures and self-consciousness on trait attributions. J Res Pers 1978; 12(4): 431-8.
  33. Bernstein WM, Davis MH. Perspective-taking, self-consciousness, and accuracy in person perception. Basic Appl Soc Psychol 1982; 3(1): 1-19.
  34. Kiropoulos L, Ward N, Rozenblat V. Self-concept, illness acceptance and depressive and anxiety symptoms in people with multiple sclerosis. J Health Psychol 2021; 26(8): 1197-206.
  35. Tunnel G. The discrepancy between private and public selves: Public self-consciousness and its correlates. J Pers Assess 1984; 48(5): 549-55.
  36. Froming WJ, Carver CS. Divergent influences of private and public self-consciousness in a compliance paradigm. J Res Pers 1981; 15(2): 159-71.
  37. Hope DA, Heimberg RG. Public and private self-consciousness and social phobia. J Pers Assess 1988; 52(4): 626-39.
  38. Chen MH, Goverover Y. Self-awareness in multiple sclerosis: Relationships with executive functions and affect. Eur J Neurol 2021; 28(5): 1627-35.
  39. Darviri C, Zavitsanou C, Delikou A, Giotaki A, Artemiadis A, Anagnostouli M, et al. Pythagorean Self-Awareness Serves Successfully as a New Cognitive Behavioral-Based Technique in Multiple Sclerosis Physical and Psychosocial Well-Being and Quality of Life. Psychol 2016; 7: 572-83.
  40. Kalron A, Aloni R. Contrasting relationship between depression, quantitative gait characteristics and self-report walking difficulties in people with multiple sclerosis. Mult Scler Relat Disord 2018; 19: 1-5.
  41. Schlenker BR, Leary MR. Social anxiety and self-presentation: A conceptualization and model. Psychol Bull 1982; 92(3): 641-69.
  42. Buss AH. Self-consciousness and social anxiety. California, CA: W.H.Freeman & Co Ltd; 1980.
  43. Crouch TA, Reas HE, Quach CM, Erickson TM. Does depression in multiple sclerosis mediate effects of cognitive functioning on quality of life? Qual Life Res 2022; 31(2): 497-506.
  44. Carone DA, Benedict RH, Munschauer FE, 3rd, Fishman I, Weinstock-Guttman B. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS. J Int Neuropsychol Soc 2005; 11(5): 574-83.
  45. Kinsinger SW, Lattie E, Mohr DC. Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology 2010; 24(5): 573-80.
  46. Wang FM, Davis MF, Briggs FB. Predicting self-reported depression after the onset of multiple sclerosis using genetic and non-genetic factors. Mult Scler 2021; 27(4): 603-12.
  47. Fischer A, Fischer M, Nicholls RA, Lau S, Poettgen J, Patas K, et al. Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. Brain Behav 2015; 5(9): e00365.
  48. Kidd T, Carey N, Mold F, Westwood S, Miklaucich M, Konstantara E, et al. A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life. PLoS One 2017; 12(10): e0185931.
  49. Genova HM, Lancaster K, Lengenfelder J, Bober CP, DeLuca J, Chiaravalloti ND. Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple sclerosis. J Neuropsychol 2020; 14(2): 213-25.
  50. Lester K, Stepleman L, Hughes M. The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 2007; 30(2): 177-86.
  51. Gottberg K, Einarsson U, Fredrikson S, von Koch L, Holmqvist LW. A population-based study of depressive symptoms in multiple sclerosis in Stockholm County: Association with functioning and sense of coherence. J Neurol Neurosurg Psychiatry 2007; 78(1): 60-5.
  52. Widiger TA, Oltmanns JR. Neuroticism is a fundamental domain of personality with enormous public health implications. World Psychiatry 2017; 16(2): 144-5.
  53. Bruce JM, Lynch SG. Personality traits in multiple sclerosis: Association with mood and anxiety disorders. J Psychosom Res 2011; 70(5): 479-85.
  54. Gay MC, Bungener C, Thomas S, Vrignaud P, Thomas PW, Baker R, et al. Anxiety, emotional processing and depression in people with multiple sclerosis. BMC Neurol 2017; 17(1): 43.